Groundbreaking Lymphatic Interventions and Drug Exploration
ID: 355758Type: Posted
Overview

Buyer

Advanced Research Projects Agency for Health (HHS-ARPAH)

Award Range

$1 - $50M

Eligible Applicants

Small Businesses

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Other

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355758

Additional Information

https://sam.gov/opp/29ef33c275b24adcaec1384e2643f7cd/view
Timeline
    Description

    The Advanced Research Projects Agency for Health (ARPA-H) is offering a federal grant opportunity titled "Groundbreaking Lymphatic Interventions and Drug Exploration" (GLIDE) aimed at fostering innovative solutions in lymphatic health. This initiative seeks to engage small businesses in developing groundbreaking interventions and drug exploration strategies, with a focus on enhancing health outcomes related to the lymphatic system. The program is critical for advancing research and development in science and technology, with funding available ranging from $1 to $50 million. Interested applicants should note that the proposal submission deadline is October 31, 2024, and can reach out to the GLIDE Team at GLIDE@arpa-h.gov for further inquiries. Additional details can be found on the SAM.gov posting.

    Point(s) of Contact
    GLIDE@arpa-h.gov
    Files
    No associated files provided.
    Similar Opportunities
    Resilient Systems Office: Office-Wide Innovative Solutions Opening for Advanced Research Projects Agency for Health
    Active
    Advanced Research Projects Agency for Health
    The Advanced Research Projects Agency for Health (ARPA-H) is inviting small businesses to submit proposals for innovative solutions aimed at addressing systemic challenges in healthcare through its Resilient Systems Office initiative. The agency seeks projects that enhance the adaptability, reliability, and interoperability of health systems, focusing on areas such as sociotechnical system innovation, health ecosystem integration, and adaptive solutions to improve health outcomes and reduce fragility in the healthcare landscape. This opportunity is critical for fostering advancements in health technologies and methodologies, with an expected 100 awards available. Proposals are due by March 14, 2025, and interested parties can contact Mark Baxter at mark.baxter@arpa-h.gov for further information.
    Proactive Health Office: Office-Wide Innovative Solutions Opening for Advanced Research Projects Agency for Health
    Active
    Advanced Research Projects Agency for Health
    The Advanced Research Projects Agency for Health (ARPA-H) is inviting proposals for the "Proactive Health Office: Office-Wide Innovative Solutions Opening," aimed at advancing research projects that enhance health outcomes and healthspan for Americans. The initiative seeks innovative solutions focused on disease prevention, early detection methods, and system-level innovations to promote proactive health behaviors and interventions. This opportunity is particularly significant as it addresses the need for a shift from reactive medical treatments to proactive health strategies, emphasizing the importance of improving overall public health. Proposals are due by March 14, 2025, and interested applicants, specifically small businesses, can reach out to Mark Baxter at mark.baxter@arpa-h.gov for further information. Additional details can be found at the provided link.
    Ocular Laboratory for Analysis of Biomarkers (OCULAB)
    Active
    Advanced Research Projects Agency for Health
    The Advanced Research Projects Agency for Health (ARPA-H) is offering a funding opportunity for the Ocular Laboratory for Analysis of Biomarkers (OCULAB) Program, aimed at supporting innovative research and development in biomarker analysis. This initiative anticipates multiple awards and is designed to facilitate collaboration among researchers, with a Proposers' Day event scheduled to enhance understanding of the program and encourage teaming among potential proposers. The opportunity is open to unrestricted applicants, with no cost-sharing requirements, and the application deadline is set for April 14, 2025. For further details, interested parties can contact ARPA-H at OCULAB@ARPA-H.gov or visit the SAM.gov posting at the provided link.
    Scalable Solutions Office: Office-Wide Innovative Solutions Opening for Advanced Research Projects Agency for Health
    Active
    Advanced Research Projects Agency for Health
    The Advanced Research Projects Agency for Health (ARPA-H) is inviting proposals for the "Scalable Solutions Office: Office-Wide Innovative Solutions," aimed at enhancing healthcare access and affordability through innovative research and development projects. Proposals should focus on scalable technologies and interventions, collaborative distribution networks, and biomanufacturing innovations that address healthcare disparities, particularly in underserved communities. This initiative is critical for developing solutions that can be rapidly deployed and adapted to various contexts, ultimately improving health outcomes across diverse populations. Interested small businesses must submit their proposals by March 14, 2025, and can contact Mark Baxter at mark.baxter@arpa-h.gov for further information.
    Realize Energy-rich Compound Opportunities Valorizing Extraction from Refuse waters (SBIR/STTR)
    Active
    Advanced Research Projects Agency Energy
    The Advanced Research Projects Agency - Energy (ARPA-E) is offering a funding opportunity titled "Realize Energy-rich Compound Opportunities Valorizing Extraction from Refuse waters (SBIR/STTR)" aimed at small businesses. This initiative seeks to develop innovative technologies for concentrating and recovering high-value energy materials, such as ammonia and critical metals, from aqueous waste streams, thereby enhancing U.S. energy security and reducing greenhouse gas emissions. The program is significant as it addresses the need for sustainable recovery methods that can replace imports of these materials while also lowering energy demand. Interested applicants can apply for funding ranging from $1.5 million to $4 million, with a total estimated program funding of $36 million and an expected 16 awards. The application deadline is December 31, 2024, and further details can be found on the ARPA-E eXCHANGE website or by contacting ARPA-E CO at arpa-e-co@hq.doe.gov.
    Realize Energy-rich Compound Opportunities Valorizing Extraction from Refuse waters (RECOVER)
    Active
    Advanced Research Projects Agency Energy
    The Advanced Research Projects Agency - Energy (ARPA-E) is offering a funding opportunity titled "Realize Energy-rich Compound Opportunities Valorizing Extraction from Refuse waters (RECOVER)" aimed at developing technologies to recover high-value energy materials from aqueous waste streams. The program seeks to concentrate and recover materials such as ammonia and critical metals from various waste sources, including municipal wastewater and oil and gas flowback, with the goal of enhancing U.S. energy security and significantly reducing energy demand and greenhouse gas emissions. With an estimated total program funding of $36 million, ARPA-E plans to award between $1.5 million and $4 million to approximately 16 projects, and interested applicants must submit their proposals through the ARPA-E eXCHANGE platform by December 31, 2024, at 9:30 a.m. Eastern Time. For further inquiries, applicants can contact ARPA-E at arpa-e-co@hq.doe.gov.
    HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management," aimed at addressing the national opioid public health crisis. This initiative encourages small businesses to develop innovative, non-addictive therapies and technologies for improved pain management, including new medications, pain-assessment devices, and treatment strategies for chronic pain. The funding available includes up to $275,766 for Phase I and $1,838,436 for Phase II grants, with applications due by April 4, 2025. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    DOD Glioblastoma, Transformative Consortium Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Glioblastoma Transformative Consortium Award, aimed at advancing research to improve outcomes for glioblastoma patients. This grant seeks proposals for innovative, multidisciplinary projects that collectively address a central hypothesis, requiring collaboration among at least four distinct projects and the inclusion of a consumer advocate. With an estimated total program funding of $9 million, the application process includes a pre-application deadline of December 23, 2024, and a full application deadline of January 13, 2025. Interested applicants can reach the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507 for further assistance.
    SEEDING CRITICAL ADVANCES FOR LEADING ENERGY TECHNOLOGIES WITH UNTAPPED POTENTIAL (SCALEUP) READY
    Active
    Advanced Research Projects Agency Energy
    The Advanced Research Projects Agency – Energy (ARPA-E) is offering a funding opportunity under the Seeding Critical Advances for Leading Energy Technologies with Untapped Potential (SCALEUP) Ready program, aimed at supporting the scaling of high-risk energy technologies that have previously received ARPA-E funding. This initiative emphasizes the importance of translating bench-scale achievements into commercially viable solutions while fostering collaboration with commercialization partners to enhance market viability. With an anticipated funding pool of approximately $50 million per fiscal year, eligible applicants include organizations holding patents on inventions conceived during ARPA-E awards, and applications are accepted continuously until amended. For more information, interested parties can visit the ARPA-E website at https://arpa-e-foa.energy.gov or contact ARPA-E CO at ARPA-E-CO@hq.doe.gov.
    HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the HEAL Initiative aimed at developing innovative therapies and technologies for enhanced pain management. This initiative specifically seeks applications from small businesses focused on creating non-addictive pain treatment alternatives, objective pain measurement tools, and new screening methodologies to address the national opioid crisis. With an annual funding projection of up to $8 million for 5-15 awards, eligible applicants must be U.S. small businesses, and the application deadline is set for April 4, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-23-006.html.